About: Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1987

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1987 (uk) im August 1987 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1987 (ast) scientific article published on 01 August 1987 (en)
publication date	wds:Q69426532-1F6633F7-19A4-458D-A737-143F365BBC71
publication date	1987-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q69426532-00562836-5A9B-4D6B-9658-3EE5DBB53398 wds:Q69426532-0592E7AF-832D-4AAF-B6C4-C860EC515412 wds:Q69426532-193D409E-F626-4419-92C3-AD982BACD156 wds:Q69426532-4CA2DE68-B735-4D65-89D5-82976E40419C
author name string	Lemoine NR Hall PA Kadar N Barnard NJ
rdfs:label	Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (en) Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (nl)
skos:prefLabel	Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (en) Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (nl)
name	Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (en) Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (nl)
title	wds:Q69426532-063E4207-3EB9-478B-AD35-76CB8B7D95F3
title	Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables (en)
page(s)	wds:Q69426532-2A93A60F-58CA-48F4-8D61-7B214C0E0FBC
page(s)	287-295
instance of	wds:Q69426532-ED1AEDA8-ACD6-4110-BFDD-AC39D87D4BB5
instance of	scholarly article
main subject	wds:Q69426532-348FCF59-79BF-413E-A8D5-4B77A6B0B674
main subject	breast carcinoma
PubMed ID	wds:Q69426532-A0129AA4-AC14-4FC6-8EAC-892BC5913874
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3668731
PubMed ID	3668731
published in	wds:Q69426532-C9029253-0A75-4119-A607-D2156E61B3D9
published in	Journal of Pathology
issue	wds:Q69426532-A22446DC-B7A9-49FF-A9CF-F1A24B7C1787
volume	wds:Q69426532-C29C1BE9-F913-4974-9DBE-0E274C65A633
issue	4
volume	152
DOI	wds:Q69426532-D4B2599E-EC0C-4328-B05F-45BC42790711
DOI	http://dx.doi.org/10.1002/PATH.1711520407
DOI	10.1002/PATH.1711520407
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69426532
is cites work of	Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers? Immunohistochemical evaluation with Ki-67: an application to salivary gland tumours Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10 Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67 Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer Ki-67 immunostaining in human breast tumors and its relationship to prognosis The value of assessing cell proliferation in breast cancer Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumours Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction Role of the Cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Ki67 immunostaining in primary breast cancer: pathological and clinical associations Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment Measuring proliferation in breast cancer: practicalities and applications Proliferation markers in tumours: interpretation and clinical value Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1 A comparative study of cell proliferation markers in breast carcinomas Ki-67 antigen expression and growth pattern of basal cell carcinomas Apocrine adenosis: a precursor of aggressive breast cancer? Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. Biological characterisation of breast cancer by means of PET. Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Correlation with prognostic features Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications Review: assessment of cell proliferation in histological material Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer. Ki-67 Immunostaining in Uveal Melanoma The association between epithelial proliferation and disease progression in the oral mucosa. Long-range, nonautonomous effects of activated Notch1 on tissue homeostasis in the nail. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas. Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry Nuclear characteristics as indicators of prognosis in node negative breast cancer patients Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors Argyrophilic Nuclear Organizer Region Counts and Ki-67 Scores in Human Renal Cell Carcinoma Ki-67 is an indicator of progression of neuroendocrine tumors Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients Proliferation, basement membrane changes, metastasis and vascularization patterns in human breast cancer Estrogen, Progesterone Receptors and Proliferating Activity Evaluated by Immunocytochemistry in Breast Cancer Application of the Monoclonal Antibody Ki-67 on Prostate Biopsies to Assess the Proliferative Cell Fraction of Human Prostatic Carcinoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software